Australia's most trusted
source of pharma news
Tuesday, 9 December 2025
Tuesday, 9 December 2025
Subscribe
Login
Aussie jobs go in latest cost-cutting
The latest round of cost-cutting at this Big Pharma has hit Australia with an undisclosed number of job losses, as the company tightens spending.
Top speed launch of first generic
From ARTG to pharmacy shelves in under a month, Arrotex has wasted no time launching generic competition to this GSK drug
TODAY
Data justifies hefty drug price tag
New data shows long-term durability of an expensive gene-therapy recently recommended for funding. Next, convince the Govt
TODAY
Ex-Aussie GM writing tell-all book
Despite reaching career heights most pharma executives can only dream of, this boss offers a reality check about the meaning of success
8 December
Is ANZ Pharma ready for 2026?
Disruption across pharma will heighten in 2026. Are leaders ready? We're asking professionals from across the industry to take this survey
8 December
$130K fine for Aussie Code breach
Committee rules company material to be "misleading" after complaints from a rival, with an additional penalty for failing on Appeal
5 December
TGA considers $4M treatment
The single shot gene therapy could reduce uptake of competitor drugs used for the disease which earn $100M annually on the PBS
5 December
Latest Jobs
4PL Logistics LeadResearch Governance OfficerMedical RepresentativeSenior Recruitment ConsultantMedical ManagerMedical information and governance associateFinance & Admin OfficerSpecialist Account Manager24 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (12)
- Medical Representative - Sunshine Coast
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
- Devices Territory Manager - Brisbane
- Medical Sales Representative - Wollongong
- Clinical Research, Business Development Manager - China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
Clinical & Medical, R&D (9)
- Research Governance Officer - Camberwell
- Medical Representative - Sunshine Coast
- Medical Manager - Sydney
- Medical information and governance associate - Sydney
- Medical Sales Representative - Wollongong
- Clinical Research, Business Development Manager - China - Shanghai, China
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Clinical Sales Specialist - Sydney
Regulatory, Pharmacovigilance & QA (3)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Devices (1)
Executive Roles (3)
- Compliance & Legal Director - Macquarie Park
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (12)
- 4PL Logistics Lead - North Sydney
- Senior Recruitment Consultant - Sydney
- Finance & Admin Officer - Macquarie Park
- Service Administrator - Belrose
- Freight & Distribution Specialist - Macquarie Park
- Warehouse Assistant - Rydalmere
- Finance Business Partner - Surry Hills
- Technical Service & Warehouse Coordinator - Alexandria
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
New data paves way for MSAC win
Pfizer announces impressive phase 3 results for its new haemophilia treatment which is under review by the MSAC
8 December
MSD tries again for broad listing
Company takes another crack at a multi-cancer recommendation alongside other submissions at PBAC's Dec Intracycle Meeting
8 December
$48 million market sees first threat
First generic of a diabetes drug has been registered on the ARTG, while competition for a cancer drug heats up
8 December Approvals Action
Meet ANZ's newest Country bosses
ICYMI: Three companies are going into 2026 with new bosses at the helm plus the other most popular stories this week
5 December Your Week in 5 Minutes
$57M patent lost, more to follow?
An appeal to reinstate a patent has been denied by the Full Federal Court, but the reasons may place other drugs at risk
5 December
PBS listing delivers gift of time
December reimbursement means treatment time for these patients will be slashed from three hours to just 10 minutes
5 December
Novo team pedals to $100K
Aussie staffers riding high after surpassing their fundraising goal in a gruelling charity event for research into type 1 diabetes
4 December
What really drives Dr prescribing?
New survey dives deep into what's really driving prescribing decisions made by Australian doctors, and what makes them switch treatment
4 December
Lilly collabs with Aussie superstar
Partners with Aussie Hollywood heart throb to create a TV special raising awareness about Alzheimer's disease
4 December
Ex-MA boss launches new venture
Enters partnership to introduce an AI-driven healthcare performance and funding tool into Australia to underpin system reform
4 December
Rare disease renovation required
New report calls for Govt to establish an Office of Rare Disease alongside other recommendations to improve treatment in rare
4 December
Industry body shuts over funding
After 10 years, this high-profile organisation has been forced to close its doors due to funding challenges
3 December
Another Country Leader named
The third new Australian Country Leader to be named in the space of 24 hours with a local exec appointed General Manager
3 December
MS cases and costs skyrocket
New report finds a record number of Australians are living with the disease and the significant burden economic as well as physical
3 December